跳到正文
研踪PaperTrail
← 研踪 PaperTrail

arXiv:2609.37022 · v2

Physics-Informed Multi-Agent Coordination for Hospital Patient Flow Optimization

首次提交 2026-09-29 16:38
版本更新 2026-11-09 14:47
雷达观测 2026-11-10 13:18
arXiv ↗PDF ↗

摘要

Efficient patient flow coordination across autonomous hospital departments is critical for mitigating overcrowding and balancing resource utilization. While classical queueing theory, specifically open Baskett--Chandy--Muntz--Palacios (BCMP) networks, provides an interpretable mathematical topology for healthcare operations, analytical models rely on stationary assumptions and fixed routing matrices that degrade under state-dependent real-world dynamics. Conversely, centralized reinforcement learning approaches struggle to accommodate the decentralized structure of hospital governance, where individual clinical departments function with localized observations, heterogeneous resources, and divergent operational objectives. In this paper, we present a Multi-Agent Systems (MAS) framework titled \emph{Physics-Informed Multi-Agent Coordination}, which embeds empirically calibrated BCMP queueing topologies as physical priors within a decentralized multi-agent reinforcement learning architecture. Formulated as a Decentralized Partially Observable Markov Decision Process (Dec-POMDP) under coupled resource constraints, our method enables autonomous departmental agents to cooperatively negotiate patient routing and dynamic service scaling. To mitigate environmental non-stationarity without inducing excessive communication overhead, agents exchange localized action fingerprints along network edges and optimize a spatially decomposed reward structure. Empirical evaluations driven by real-world MIMIC-IV patient trajectories indicate that this cooperative multi-agent approach substantially reduces cumulative system delay compared to static Markovian approximations, heuristic dispatching, and independent multi-agent baselines, while maintaining clinical safety constraints.

作者备注:Accepted to PRIMA 2026 (Full paper). 16 pages, 2 figures, 3 tables

AI 论文解读

基于摘要 · 非全文审阅

此版本尚未生成 AI 解读。解读由后台任务生成并按论文版本保存,登录后共享已有结果。

版本差异

目前只观测到一个版本,无法比较变化。之后收录新版本时,会在这里对照标题、作者、分类和摘要。

观测到的版本

相邻记录可能跳过中间版本;首次发现 v2 及以上也会标为版本更新。

v2 · 2026-11-09 14:47 · 最新观测版本

Physics-Informed Multi-Agent Coordination for Hospital Patient Flow Optimization

Efficient patient flow coordination across autonomous hospital departments is critical for mitigating overcrowding and balancing resource utilization. While classical queueing theory, specifically open Baskett--Chandy--Muntz--Palacios (BCMP) networks, provides an interpretable mathematical topology for healthcare operations, analytical models rely on stationary assumptions and fixed routing matrices that degrade under state-dependent real-world dynamics. Conversely, centralized reinforcement learning approaches struggle to accommodate the decentralized structure of hospital governance, where individual clinical departments function with localized observations, heterogeneous resources, and divergent operational objectives. In this paper, we present a Multi-Agent Systems (MAS) framework titled \emph{Physics-Informed Multi-Agent Coordination}, which embeds empirically calibrated BCMP queueing topologies as physical priors within a decentralized multi-agent reinforcement learning architecture. Formulated as a Decentralized Partially Observable Markov Decision Process (Dec-POMDP) under coupled resource constraints, our method enables autonomous departmental agents to cooperatively negotiate patient routing and dynamic service scaling. To mitigate environmental non-stationarity without inducing excessive communication overhead, agents exchange localized action fingerprints along network edges and optimize a spatially decomposed reward structure. Empirical evaluations driven by real-world MIMIC-IV patient trajectories indicate that this cooperative multi-agent approach substantially reduces cumulative system delay compared to static Markovian approximations, heuristic dispatching, and independent multi-agent baselines, while maintaining clinical safety constraints.

查看此版本解读 →查看此版本原文 ↗